Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
DURECT Corporation (NASDAQ: DRRX) shares declined 20.51 percent to close at $1.55 a share Thursday. The stock traded between $1.32 and $1.55 on volume 9.44 million shares traded. The company announced that the FDA did not approve the New Drug Application for POSIDUR (SABER®-Bupivacaine). Shares of DURECT are down approximately 10.0 percent year-to-date.
Get more information on DURECT free access to the in-depth equity report at:
Ion Geophysical Corp. (NYSE: IO) shares soared 29.21 percent to close at $4.07 a share Thursday. The stock traded between $3.75 and $4.10 on volume 19.41 million shares traded. The company reported revenues were a record $218.7 million for the fourth quarter of 2013, an increase of 26.0 percent when compared to a year ago. Shares of Ion Geophysical are up approximately 23.0 percent year-to-date.
Get more information on Ion Geophysical and free access to the in-depth equity report at:
NetApp Inc. (NASDAQ: NTAP) shares declined 3.50 percent to close at $41.10 a share Thursday. The stock traded between $39.85 and $41.25 on volume of 11.23 million shares traded. The company reported net sales were $1.61 billion for the third quarter of fiscal 2014, a decrease of 1.2 percent when compared to a year ago. Shares of NetApp are up approximately 15.0 percent in the past year.
Get more information on NetApp and free access to the in-depth equity report at:
URS Corp. (NYSE: URS) shares fell 13.88 percent to close at $42.51 a share Thursday. The stock traded between $41.62 and $43.53 on volume of 6.51 million shares traded. The company now expects fully diluted EPS to be in the range of $3.20 and $3.30 for fiscal 2013, down from its previous guidance of $4.10 to $4.25 a share. Shares of URS are down approximately 20.0 percent year-to-date.
Get more information on URS and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities